Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03057158 · ClinicalTrials.gov registry record
Genomics and Epigenomics for New Insights in fEmale OAB (GENIE) Study
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 257
- Enrollment target
NCT03057158: Completed study, sponsored by Duke University.
NCT03057158 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 257 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03057158 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 257 participants
- Enrollment target
Study Summary
Millions of women suffer from overactive bladder, and the changes in bladder function affect their quality of life. The study team believes that it needs to be better understand why women get overactive bladder in the first place so that better treatments can eventually be offered. The purpose of this study is to determine why women with insulin resistance are more likely to get overactive bladder. Overactive bladder is a type of bladder control problem that can cause some women to have bladder leakage. This problem is more common in women with diabetes and pre-diabetes, but it isn't known why.
Primary Outcome
Extract DNA from voided urine cells and compare human DNA using Illumina EPIC Methylation Chip to assess methylation of different sites across the genome
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2020-03-11 |
What the finished NCT03057158 record still lists
NCT03057158 is an observational study that tracks outcomes without assigning an intervention. The registered 257 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03057158 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03057158 about?
NCT03057158 is a clinical study titled "Genomics and Epigenomics for New Insights in fEmale OAB (GENIE) Study". Millions of women suffer from overactive bladder, and the changes in bladder function affect their quality of life. The study team believes that it needs to be better understand why women get overactive bladder in the first place so that better treatments can eventually be offered. The purpose of t...
What is the current status of trial NCT03057158?
This trial is currently completed. The enrollment target is 257 participants. The study started on 2017-05-01. Estimated completion is 2020-03-11.
Who is sponsoring clinical trial NCT03057158?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03618550 · 257 participants · Phase 2
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- NCT04674267 · 257 participants · NA
Resilience and Equity in Aging, Cancer, and Health (REACH)
- NCT06099288 · 257 participants · NA
Strong Families Start at Home/Familias Fuertes Comienzan en Casa
- NCT06207084 · 257 participants · NA
The Fit With Us Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI